Progressive histopathological changes and β-cell loss in the pancreas of a new spontaneous rat model of type 2 diabetes

Tissue and Cell

Volumn 44, Issue 2, 2012, Pages 101-110

  Riccillo, F L ^a   Bracamonte, M I ^b   Montenegro, S ^c   Martinez S M ^c   Ronderos, J R ^a,d  

^a Centro Regional de Estudios Genómicos CREG UNLP   (Argentina)

^b Cátedra de Citología Histología y Embriología B FCM UNLP   (Argentina)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^d UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

Immunohistochemistry; Pancreas; Rat; Type 2 diabetes; Cells

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL DIFFERENTIATION; CELL DIVISION; CELL LOSS; CELL POPULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOPATHOLOGY; DISEASE COURSE; ENDOCRINE CELL; FIBROSING ALVEOLITIS; GENERAL PATHOLOGICAL PARAMETERS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; SURVIVAL; TRIACYLGLYCEROL BLOOD LEVEL; VOLUME DENSITY;

ANIMALIA; RATTUS;

EID: 84857192583     PISSN: 00408166     EISSN: 15323072     Source Type: Journal    
DOI: 10.1016/j.tice.2011.12.002     Document Type: Article

References (55)

1. Apte M.V., Haber P.S., Darby S.J., Rodgers S.C., McCaughan G.W., Korsten M.A., Pirola R.C., Wilson J.S. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 1999, 44:534-541.
2. Bachem M.G., Schneider E., Groß H., Weidenbach H., Schmid R.M., Menke A., Siech M., Beger H., Grünert A., Adler G. Identification, culture and characterisation of pancreatic stellate cells in rats and humans. Gastroenterology 1998, 115:421-432.
3. Bals R. Cell types of respiratory epithelium: morphology, molecular biology and clinical significance. Pneumologie 1997, 51:142-149.
4. Bergman R.N., Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 2000, 1:351-356.
5. Bernard C., Ktorza A. Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes 2001, 50(Suppl. 1):s30-s35.
6. Bernard C., Berthault M.-F., Saulnier C., Ktorza A. Neogenesis vs. apoptosis as main components of pancreatic β-cell mass changes in glucose-infused normal and mildly diabetic adult rats. FASEB J. 1999, 13:1195-1205.
7. Boden G., Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur. J. Clin. Invest. 2002, 32(Suppl. 3):14-23.
8. Bonner-Weir S. β-Cell turnover. Its assessment and implications. Diabetes 2001, 50(Suppl. 1):s20-s24.
9. Bouwens L. Transdifferentiation versus stem cell hypothesis for the regeneration of islet beta-cells in the pancreas. Microsc. Res. Tech. 1998, 43:332-336.
10. Bouwens L. Cytokeratins and cell differentiation in the pancreas. J. Pathol. 2000, 184:234-239.
11. Calderari S.A., Martínez S.M., Tarrés M.C., Picena J.C., Rabasa S.L. Modelos hereditarios de diabetes y obesidad humanas en líneas endocriadas de ratas vinculadas por ascendencia. Mendeliana 1995, 11:47-55.
12. Clark A., Nilsson M.R. Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes?. Diabetologia 2004, 47:157-169.
13. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
14. Donath M.Y., Storling J., Maedler K., Mandrup-Poulsen T. Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes. J. Mol. Med. 2003, 81:455-470.
15. Finegood D.T., Scaglia L., Bonner-Weir S. Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 1995, 44:249-256.
16. Gerich J. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev. 1998, 19:491-503.
17. Gerich J. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin. Proc. 2003, 78:447-456.
18. Gómez Dumm C.L.A., Semino M.C., Gagliardino J.J. Quantitative morphological changes in endocrine pancreas of rats with spontaneous diabetes mellitus. Virchows Archiv. B Cell Pathol. 1989, 57:375-381.
19. Gómez Dumm C.L.A., Semino M.C., Gagliardino J.J. Sequential morphological changes in pancreatic islets of spontaneously diabetic rats. Pancreas 1990, 5:533-539.
20. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29:415-445.
21. Haataja L., Gurlo T., Huang C.J., Butler P.C. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr. Rev. 2008, 29(3):303-316.
22. Hardy R.W., Meckling-Gill K.A., Williford J., Desmond R.A., Wei H. Energy restriction reduces long-chain saturated fatty acids associated with plasma lipids in aging male rats. J. Nutr. 2002, 132(10):3172-3177.
23. Homo-Delarche F., Calderari S., Irminger J.C., Rickenbach K., Gangnerau M.N., Coulaud J., Dolz M., Halban P., Portha B., Serradas S. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 2006, 55:1625-1633.
24. Hong E.-G., Noh H.-L., Lee S., Chung Y.-S., Lee K.-W., Kim H.-M. Insulin and glucagon secretions and morphological change of pancreatic islet in OLETF rats: a model of type 2 diabetes mellitus. J. Korean Med. Sci. 2002, 17:34-40.
25. Janssen S.W., Hermus A.R., Lange W.P., Knijnenburg Q., van der Laak J.A., Sweep C.G., Martens G.J., Verhofstad A.A. Progressive histopathological changes in pancreatic islets of Zucker diabetic fatty rats. Exp. Clin. Endocrinol. Diabetes 2001, 109(5):273-282.
26. Kahn S.E. The importance of beta-cell failure in the development and progression of type 2 diabetes. J. Clin. Endocrinol. Metab. 2001, 86:4047-4058.
27. Kahn S.E. The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003, 46:3-19.
28. Klöppel G., Detlefsen S., Feyerabend B. Fibrosis of the pancreas: the initial tissue damage and the resulting pattern. Virchows Arch. 2004, 445(1):1-8.
29. Ko S.H., Kwon H.S., Kim S.R., Moon S.D., Ahn Y.B., Song K.H., Son H.S., Cha B.Y., Lee K.W., Son H.Y., Kang S.K., Park C.G., Lee I.K., Yoon K.H. Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Biochem. Biophys. Res. Commun. 2004, 316:114-122.
30. Kolb H., Mandrup-Poulsen T. An immune origin of type 2 diabetes?. Diabetologia 2005, 48:1038-1050.
31. Koyama M., Wada R., Sakuraba H., Mizukami H., Yagihashi S. Accelerated Loss of Islet B Cells in Sucrose-Fed Goto-Kakizaki Rats: a Genetic Model of Non-Insulin-Dependent Diabetes Mellitus. Am. J. Pathol. 1998, 153:537-545.
32. Martínez S.M., Tarres M.C., Picena J.C., Montenegro S.M., Gagliardino J.J., Gomez Dumm C.L.A., D'Ottavio A.E., Naves A., Rabasa S.L. eSS rat: an animal model for the study of spontaneous non-insulin-dependent diabetes. Lessons from Animal Diabetes IV 1993, 75-90. Smith-Gordon. E. Shafrir (Ed.).
33. Martinez S.M., Tarres M.C., Montenegro S.M., Varela M., Torrano A., D'Ottavio A.E., Naves A., Picena J.C. Effects of dietary sucrose option on the diabetic syndrome of the eSS rat. Israel J. Med. Sci. 1994, 30:761-766.
34. Masuyama T., Komeda K., Hara A., Noda M., Shinohara M., Oikawa T., Kanazawa Y., Taniguchi K. Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats. Biochem. Biophys. Res. Commun. 2004, 314:870-877.
35. Movassat J., Saulnier C., Serradas P., Portha B. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat. Diabetologia 1997, 40:916-925.
36. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric reaction. Anal. Biochem. 1979, 95:351-358.
37. Omary M.B., Lugea A., Lowe A.W., Pandol S.J. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J. Clin. Invest. 2007, 117:50-59.
38. Picena J.C., Montenegro S.M., Tarrés M.C., Martinez S.M. Modificaciones dinámicas en los islotes de Langerhans de dos líneas de ratas espontáneamente diabéticas. Medicina 2007, 67:331-340.
39. Pick A., Clark J., Kubstrup C., Levisetti M., Pugh W., Bonner-Weir S., Polonsky K.S. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and B-cell defects in the male Zucker diabetic fatty rats. Diabetes 1998, 47:358-364.
40. Pimenta W., Korytkowski M., Mitrakou A., Jenssen T., Yki-Jarvinen H., Evron W., Dailey G., Gerich J. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 1995, 273:1855-1861.
41. Plachot C., Movassat J., Portha B. Impaired B-cell regeneration after partial pancreatectomy in the adult Goto-Kakizaki rat: a spontaneous model of type II diabetes. Histochem. Cell Biol. 2001, 116:131-139.
42. Poitout V., Robertson R.P. Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr. Rev. 2008, 29(3):351-366.
43. Porte D. β-Cells in type II diabetes mellitus. Diabetes 1991, 40:166-180.
44. Robertson R.P., Harmon J., Tran P.O., Tanaka Y., Takahashi H. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003, 52:581-587.
45. Robertson R.P., Harmon J., Tran P.O., Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004, 53(Suppl. 1):S119-S124.
46. Rocha V.Z., Libby P. Obesity, inflammation, and atherosclerosis. Nat. Rev. 2011, 6(6):399-409.
47. Shafrir E. Animal models of non-insulin-dependent diabetes. Diabetes Metab. Rev. 1992, 8(3):179-208.
48. Shafrir E., Ben-Sasson R., Ziv E., Bar-On H. Insulin resistance, β-cell survival, and apoptosis in type 2 diabetes: animal models and human implications. Diabetes Rev. 1999, 7(2):114-123.
49. Shek F.W.-T., Benyon R.C., Walker F.M., McCrudden P.R., Pender S.L., Williams E.J., Johnson P.A., Johnson C.D., Bateman A.C., Fine D.R., Iredale J.P. Expression of transforming growth factor-β1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am. J. Pathol. 2002, 160:1787-1798.
50. Unger R.H., Zhou Y.-T., Orci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2327-2332.
51. Unger R.H., Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 2001, 15:312-321.
52. Unger R.H., Zhou Y.T. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001, 50(Suppl. 1):S118-S121.
53. Weir G.C., Laybutt D.R., Kaneto H., Bonner-Weir S., Sharma A. B-cell adaptation and decompensation during the progression of diabetes. Diabetes 2001, 50(Suppl. 1):s154-s159.
54. Yoshikawa H., Kihara Y., Taguchi M., Yamaguchi T., Nakamura H., Otsuki M. Role of TGF-β1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 282:G549-G558.
55. Zhu M., Noma Y., Mizuno A., Sano T., Shima K. Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima Fatty rat: a model of spontaneous NIDDM. Diabetes 1996, 45:941-946.